Rothnie, K. J., Numbere, B. ., Gelwicks, S. ., Lu, Y. ., Sharma, R. ., Compton, C. ., … Quint, J. K. (2023). Risk Factors Associated with a First Exacerbation Among Patients with COPD Classified as GOLD A and B in Routine Clinical Practice in the UK. Int J Chron Obstruct Pulmon Dis, 18, 2673–2685. http://doi.org/10.2147/copd.s413947
A. Ismaila
First name
A.
Middle name
S.
Last name
Ismaila
Ismaila, A. S., Rothnie, K. J., Wood, R. P., Banks, V. L., Camidge, L. J., Czira, A. ., … Halpin, D. M. G. (2023). Benefit of prompt initiation of single-inhaler fluticasone furoate, umeclidinium, and vilanterol (FF/UMEC/VI) in patients with COPD in England following an exacerbation: a retrospective cohort study. Respir Res, 24, 229. http://doi.org/10.1186/s12931-023-02523-1
Requena, G. ., Czira, A. ., Banks, V. ., Wood, R. ., Tritton, T. ., Castillo, C. ., … Ismaila, A. S. (2023). Comparative Effectiveness of Umeclidinium/Vilanterol versus Indacaterol/Glycopyrronium on Moderate-to-Severe Exacerbations in Patients with Chronic Obstructive Pulmonary Disease in Clinical Practice in England. Int J Chron Obstruct Pulmon Dis, 18, 2039–2054. http://doi.org/10.2147/copd.s408688
Requena, G. ., Czira, A. ., Banks, V. ., Wood, R. ., Tritton, T. ., Castillo, C. M., … Ismaila, A. S. (2023). Comparison of Rescue Medication Prescriptions in Patients with Chronic Obstructive Pulmonary Disease Receiving Umeclidinium/Vilanterol versus Tiotropium Bromide/Olodaterol in Routine Clinical Practice in England. Int J Chron Obstruct Pulmon Dis, 18, 1431–1444. http://doi.org/10.2147/copd.s411437
Czira, A. ., Requena, G. ., Banks, V. ., Wood, R. ., Tritton, T. ., Castillo, C. M., … Ismaila, A. S. (2023). Comparative Effectiveness of Umeclidinium/Vilanterol versus Inhaled Corticosteroid/Long-Acting β(2)-Agonist in Patients with Chronic Obstructive Pulmonary Disease in a Primary Care Setting in England. Int J Chron Obstruct Pulmon Dis, 18, 643–659. http://doi.org/10.2147/copd.s405498
Requena, G. ., Banks, V. ., Czira, A. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2023). Treatment Patterns, Healthcare Utilization and Clinical Outcomes of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting β(2)-Agonist/Long-Acting Muscarinic Antagonist Dual Therapy in Primary Care in England. Int J Chron Obstruct Pulmon Dis, 18, 231–245. http://doi.org/10.2147/copd.s389281
Halpin, D. M. G., Rothnie, K. J., Banks, V. ., Czira, A. ., Compton, C. ., Wood, R. ., … Vogelmeier, C. F. (2022). Comparative Adherence and Persistence of Single- and Multiple-Inhaler Triple Therapies Among Patients with Chronic Obstructive Pulmonary Disease in an English Real-World Primary Care Setting. Int J Chron Obstruct Pulmon Dis, 17, 2417–2429. http://doi.org/10.2147/copd.s370540
Czira, A. ., Banks, V. ., Requena, G. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2022). Characterisation of patients with chronic obstructive pulmonary disease initiating single-device inhaled corticosteroids/long-acting β(2)-agonist dual therapy in a primary care setting in England. BMJ Open Respir Res, 9. http://doi.org/10.1136/bmjresp-2022-001243
Requena, G. ., Banks, V. ., Czira, A. ., Wood, R. ., Tritton, T. ., Wild, R. ., … Ismaila, A. S. (2022). Characterization of Patients with Chronic Obstructive Pulmonary Disease Initiating Single-Inhaler Long-Acting Muscarinic Antagonist/Long-Acting β(2)-Agonist Dual Therapy in a Primary Care Setting in England. Int J Chron Obstruct Pulmon Dis, 17, 1781–1795. http://doi.org/10.2147/copd.s365480
Rothnie, K. J., Joksaite, S. ., Sansbury, L. B., Compton, C. ., Di Boscio, V. ., & Ismaila, A. S. (2022). Characteristics of New Users of Single- and Multiple-Inhaler Triple Therapy for COPD in Primary Care in England. Int J Chron Obstruct Pulmon Dis, 17, 1455–1466. http://doi.org/10.2147/copd.s338436